Search Results - "Nilsen, D W. T"

Holotranscobalamin and methylmalonic acid as prognostic markers following an acute myocardial infarction by Aarsetøy, H, Valente, E, Reine, A, Mansoor, M.A, Grundt, H, Nilsen, D.W.T

“…Objective: To evaluate whether low levels of holotranscobalamin (holoTC) or elevated levels of methylmalonic acid (MMA), both indicators of vitamin B12…”
Get full text

Homocysteine‐lowering therapy does not affect inflammatory markers of atherosclerosis in patients with stable coronary artery disease by Bleie, Ø., Semb, A. G., Grundt, H., Nordrehaug, J. E., Vollset, S. E., Ueland, P. M., Nilsen, D. W. T., Bakken, A. M., Refsum, H., Nygård, O. K.

“… Objectives.  A high level of total homocysteine (tHcy) is a risk marker for cardiovascular disease (CVD), and is related to inflammation. We wanted to test…”
Get full text

Characteristics and prognostic impact of plasma fibrin monomer (soluble fibrin) in patients with coronary artery disease by Hetland, Ø, Knudsen, A, Dickstein, K, Nilsen, D W. T

“…We measured fibrin monomer (FM), soluble fibrin, as a marker of thrombin activity in plasma samples obtained in parallel with the first two routine samples for…”
Get full text

Increased lipid peroxidation during long-term intervention with high doses of n-3 fatty acids (PUFAs) following an acute myocardial infarction by GRUNDT, H, NILSEN, D. W. T, MANSOOR, M. A, NORDØY, A

“…To assess the oxidative burden of a highly concentrated compound of n-3 PUFAs as compared to corn oil by measuring thiobarbituric acid-malondialdehyde complex…”
Get full text

Circulating trimethyllysine and risk of acute myocardial infarction in patients with suspected stable coronary heart disease by Bjørnestad, E. Ø., Olset, H., Dhar, I., Løland, K., Pedersen, E. K. R., Svingen, G. F. T., Svardal, A., Berge, R. K., Ueland, P. M., Tell, G. S., Nilsen, D. W. T., Nordrehaug, J. E., Nygaard, E., Nygård, O.

“…Background The carnitine precursor trimethyllysine (TML) is associated with progression of atherosclerosis, possibly through a relationship with…”
Get full text

Association of plasma neopterin with risk of an inpatient hospital diagnosis of atrial fibrillation: results from two prospective cohort studies by Zuo, H., Nygård, O., Ueland, P. M., Vollset, S. E., Svingen, G. F. T., Pedersen, E. R., Midttun, Ø., Meyer, K., Nordrehaug, J. E., Nilsen, D. W. T., Tell, G. S.

“…Background Link between inflammation and atrial fibrillation (AF) has been increasingly recognized. Neopterin, a biomarker of cellular immune activation, may…”
Get full text

Atherothrombogenic risk modulation by n-3 fatty acids was not associated with changes in homocysteine in subjects with combined hyperlipidaemia by Grundt, H, Nilsen, D W, Hetland, O, Mansoor, M A, Aarsland, T, Woie, L

“…Favourable effects of n-3 fatty acids on the atherogenic risk profile were recently demonstrated in subjects with combined (type IIb) hyperlipidaemia, not…”
Get more information

Activated factor XII type A predicts long-term mortality in patients admitted with chest pain by Pönitz, V, Brügger-Andersen, T, Pritchard, D, Grundt, H, Staines, H, Nilsen, D W T

“…We assessed the relation between admission levels of activated factor XII type A (XIIaA), and long-term all-cause and cardiac mortality and recurrent troponin…”
Get full text

Inhibitor complexes of the plasma kallikrein–kinin system and outcome prediction in patients following admission for chest pain by PÖNITZ, V., GOVERS‐RIEMSLAG, J. W. P., BRÜGGER‐ANDERSEN, T., Ten CATE, H., NILSEN, D. W. T.

Get full text

Changes in EPA and DHA during supplementation with omega-3 fatty acids and incident cardiovascular events: secondary analysis from the OMEMI trial by Myhre, P, Smith, E B, Kalstad, A A, Tveit, S, Laake, K, Smith, P, Nilsen, D W T, Tveit, A, Solheim, S, Arnesen, H, Seljeflot, I

“…Abstract Background In the OMEMI trial, elderly post-MI patients did not achieve reduction in cardiovascular events from supplementation of 1.8g n-3…”
Get full text

Improvement of serum lipids and blood pressure during intervention with n-3 fatty acids was not associated with changes in insulin levels in subjects with combined hyperlipidaemia by Grundt, H, Nilsen, D W, Hetland, O, Aarsland, T, Baksaas, I, Grande, T, Woie, L

“…To investigate the effect of an omega-3 fatty acid concentrate K85 on serum lipids, lipoproteins, insulin metabolism and blood pressure in subjects with…”
Get more information

P5380The association between apolipoprotein A1 and HDL-cholesterol with acute myocardial infarction is modified by plasma choline. A cohort study of patients with suspected stable angina pectoris by Svingen, G F T, Hepsoe, H, Ueland, P M, Schartum-Hansen, H, Seifert, R, Pedersen, E R, Nilsen, D W T, Nygaard, O K

Get full text

P627Cyclic variations of C-reactive protein levels by Schartum-Hansen, H, Seifert, R, Svingen, G F T, Ueland, P M, Pedersen, E R, Nordrehaug, J E, Nilsen, D W T, Dahr, I, Nygaard, O N

Get full text

P5801Plasma metabolites of the transsulfuration pathway and risk of new-onset atrial fibrillation among patients with stable angina pectoris by Svenningsson, M M, Svingen, G F T, Ueland, P M, Lysne, V, Ulvik, A, Tell, G S, Seifert, R, Pedersen, E R, Nilsen, D W T, Nygard, O K

Get full text

355Effects of the PAR-1 receptor antagonist vorapaxar on platelet activation and coagulation biomarkers in patients with stable coronary artery disease by Olie, R H, Van Der Meijden, P E J, Spronk, H M H, Van Oerle, R, Barvik, S, Bonarjee, V V S, Ten Cate, H, Nilsen, D W T

Get full text

Influence of a concentrated ethylester compound of n-3 fatty acids on lipids, platelets and coagulation in patients undergoing coronary bypass surgery by Nilsen, D W, Dalaker, K, Nordøy, A, Osterud, B, Ingebretsen, O C, Lyngmo, V, Almdahl, S, Vaage, J, Rasmussen, K

“…Twenty patients accepted for coronary bypass surgery were randomized to receive either a concentrated ethylester compound of n-3 fatty acids, with a daily dose…”
Get more information

Cardiac troponin T immunoassay on biotin--streptavidin-coated microplates: preliminary performance in acute myocardial infarction by Hetland, O, Goransson, L, Nilsen, D W

“…We have adapted the cardiac troponin T (TnT) immunoassay system (ELISA troponin T, Boehringer Mannheim, Germany), which is based upon streptavidin-biotin…”
Get more information

Lipopolysaccharide induced monocyte thromboplastin synthesis and coagulation responses in patients undergoing coronary bypass surgery after preoperative supplementation with n-3 fatty acids by Nilsen, D W, Almdahl, S M, Svensson, B, Vaage, J, Rasmussen, K, Osterud, B

“…Twenty patients with coronary heart disease (CHD) and elevated serum lipids were randomized into 2 groups of 10 to receive encapsulated preparations of either…”
Get more information

Plasma brain natriuretic peptide as an indicator of left ventricular systolic function and long-term survival after acute myocardial infarction : Comparison with plasma atrial natriuretic peptide and N-terminal proatrial natriuretic peptide by OMLAND, T, AAKVAAG, A, BONARJEE, V. V. S, CAIDAHL, K, LIE, R. T, NILSEN, D. W. T, SUNDSFJORD, J. A, DICKSTEIN, K

“…Elevated plasma levels of atrial natriuretic peptide (ANP) and the N-terminal fragment of the ANP prohormone (N-ANP) are associated with decreased left…”
Get full text

Cardiac resynchronization therapy improves minute ventilation/carbon dioxide production slope and skeletal muscle capillary density without reversal of skeletal muscle pathology or inflammation by Larsen, Alf Inge, Lindal, Sigurd, Myreng, Kate, Ogne, Christer, Kvaløy, Jan Terje, Munk, Peter Scott, Aukrust, Pål, Yndestad, Arne, Dickstein, Kenneth, Nilsen, Dennis W T

“…We evaluated the effects of cardiac resynchronization therapy (CRT) on skeletal muscle pathology and inflammation in patients with heart failure. Stable…”
Get full text